CALML5 and cancer: Immunotherapy has been recognized as one of the most promising therapeutic approaches for improving outcomes in various types of malignant tumors.[27] In this regard, we observed enrichments of CALML5 in immune-associated pathways, including T cell receptor signaling pathway, natural killer cell mediated cytotoxicity, and more.